Zeng et al. prepared functionalized nanoemulsions that encapsulated tumor antigens to target Clec9A (Clec9A-TNE), which can stimulate therapeutically effective tumor-specific immunity 95. This evidence concerns the gene CLEC9A and neoplasm.